Publikationen in Zusammenarbeit mit Forschern von Pharmacoeconomics and Outcomes Research Iberia (7)

2023

  1. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

2018

  1. Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study

    Current HIV Research, Vol. 16, Núm. 6, pp. 425-435

2017

  1. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain

    BMC Infectious Diseases, Vol. 17, Núm. 1

2013

  1. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 9, pp. 807-814

  2. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES

    Neurologia, Vol. 28, Núm. 6, pp. 332-339

  3. Mental health self-assessment in patients with moderate to severe psoriasis: An observational, multicenter study of 1164 patients in Spain (The VACAP study)

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 10, pp. 897-903

2012

  1. Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España

    Revista Espanola de Cardiologia, Vol. 65, Núm. 10, pp. 901-910